Want to see TENX full AI Analyst Report?
Tenax Therapeutics (TENX) Ownership - Who Owns Tenax Therapeutics?
Tenax Therapeutics (TENX) Ownership Overview
- 20.22% Insiders
- 12.13% Mutual Funds
- 0.03% Other Institutional Investors
- 8.18% ETFs
- 59.43% Public Companies and Individual Investors
The ownership structure of Tenax Therapeutics (TENX) stock is a mix of institutional, retail, and individual investors. Approximately 20.35% of the company’s stock is owned by Institutional Investors, 20.22% is owned by Insiders, and 59.43% is owned by Public Companies and Individual Investors.
The ownership structure of Tenax Therapeutics (TENX) stock is a mix of institutional, retail, and individual investors. Approximately 12.17% of the company’s stock is owned by Institutional Investors, 20.22% is owned by Insiders, and 8.18% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 20, 2026 | Adar1 Capital Management, Llc | $1,456,961 | |
| Sep 16, 2026 | Declan Doogan | $101,760 | |
| Sep 14, 2026 | Giordano Christopher Thomas | $20,047 | |
| Sep 14, 2026 | Tom Staab | $10,953 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Woodline Partners Lp | $7,729,746 | |
| Jun 30, 2026 | Perceptive Advisors Llc | $24,735,000 | |
| Jun 30, 2026 | $25,142,225 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Adar1 Capital Management, Llc | 7,447,000 | Insider | 19.90% | 13,330,130 |
| Joseph Edelman | 1,700,000 | Institution | 4.54% | 3,043,000 |
| Vanguard | 1,379,957 | Institution | 3.69% | 2,470,123 |
| Ishares | 1,341,097 | Institution | 3.58% | 2,400,564 |
| Vanguard Index Funds | 1,130,109 | Institution | 3.02% | 2,022,895 |
| Fidelity Concord Street Trust | 1,002,811 | Institution | 2.68% | 1,795,032 |
| Michael Rockefeller | 531,254 | Institution | 1.42% | 950,945 |
| Tiaa-cref Funds | 493,077 | Institution | 1.32% | 882,608 |
| T. Rowe Price Health Sciences Fund, Inc. | 445,976 | Institution | 1.19% | 798,297 |
| Fidelity Advisor Series Vii | 445,100 | Institution | 1.19% | 796,729 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 1,130,109 | Institution | 3.02% | 2,022,895 |
| Fidelity Concord Street Trust | 1,002,811 | Institution | 2.68% | 1,795,032 |
| Tiaa-cref Funds | 493,077 | Institution | 1.32% | 882,608 |
| T. Rowe Price Health Sciences Fund, Inc. | 445,976 | Institution | 1.19% | 798,297 |
| Fidelity Advisor Series Vii | 445,100 | Institution | 1.19% | 796,729 |
| Fidelity Salem Street Trust | 310,912 | Institution | 0.83% | 556,532 |
| Vanguard Scottsdale Funds | 169,315 | Institution | 0.45% | 303,074 |
| Bny Mellon Investment Funds I | 125,362 | Institution | 0.33% | 224,398 |
| Dfa Investment Dimensions Group Inc | 101,896 | Institution | 0.27% | 182,394 |
| Schwab Capital Trust | 61,174 | Institution | 0.16% | 109,501 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| iShares | 902,210 | Institution | 2.41% | 1,678,111 |
| Vanguard | 852,259 | Institution | 2.28% | 1,610,770 |
| iShares | 332,688 | Institution | 0.89% | 618,800 |
| Vanguard | 279,714 | Institution | 0.75% | 528,659 |
| Vanguard | 211,671 | Institution | 0.57% | 400,058 |
| iShares | 109,495 | Institution | 0.29% | 203,661 |
| Fidelity | 63,279 | Institution | 0.17% | 117,699 |
| Dimensional | 53,228 | Institution | 0.14% | 729,224 |
| SPDR | 47,310 | Institution | 0.13% | 87,997 |
| ALPS | 45,463 | Institution | 0.12% | 81,379 |
FAQ
Who Owns Tenax Therapeutics (TENX)?
According to the latest TipRanks data, approximately 0.03% of the company's stock is held by institutional investors, 20.22% is held by insiders, and 59.43% is held by retail investors.
What percentage of Tenax Therapeutics (TENX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.03% of Tenax Therapeutics (TENX) stock is held by institutional investors.
What percentage of Tenax Therapeutics (TENX) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.43% of Tenax Therapeutics (TENX) stock is held by retail investors.
Who owns the most shares of Tenax Therapeutics (TENX)?
ADAR1 Capital Management, LLC owns the most shares of Tenax Therapeutics (TENX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.